Nuvectis Pharma, Inc.NVCTNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-19.00M
↓ 28% below average
Average (4y)
$-14.81M
Historical baseline
Range
High:$-10000.00
Low:$-22.90M
CAGR
+560.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-19.00M | +17.0% |
| 2023 | $-22.90M | -19.0% |
| 2022 | $-19.23M | -49.2% |
| 2021 | $-12.89M | -128840.0% |
| 2020 | $-10000.00 | - |